Can trazodone cause nocturnal enuresis (bedwetting)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Trazodone Cause Bedwetting?

Yes, trazodone can cause urinary incontinence including bedwetting (nocturnal enuresis), though this is not a commonly emphasized side effect in the FDA labeling.

Evidence from FDA Drug Label

The FDA label for trazodone 1 1 1 lists urinary incontinence as a post-marketing adverse reaction under "Renal and urinary disorders." This means cases have been reported after the drug's approval, though the exact frequency cannot be determined from voluntary reporting systems. The label also mentions urinary retention as a potential adverse effect, indicating trazodone can affect bladder function in multiple ways.

Clinical Context and Mechanism

While the FDA label confirms urinary incontinence as a recognized adverse effect, the mechanism is not fully elucidated but likely relates to:

  • Sedation effects: Trazodone's primary side effect is sedation 2, which could impair arousal from sleep when the bladder is full
  • Anticholinergic properties: Though mild, these could affect bladder control
  • Central nervous system effects: Trazodone affects multiple neurotransmitter systems that may influence bladder signaling

Interestingly, one small self-study 3 found that trazodone did NOT reduce nocturia (nighttime urination frequency) compared to placebo, suggesting it doesn't improve bladder control during sleep and may even impair normal arousal mechanisms.

Clinical Implications

If a patient develops new-onset bedwetting after starting trazodone:

  • Consider trazodone as a potential causative agent
  • Evaluate timing of dose (bedtime dosing 2 may increase risk)
  • Assess for other contributing factors (fluid intake, sleep disorders, other medications)
  • Consider dose reduction or switching to an alternative antidepressant if bedwetting is problematic

Important Caveats

  • This is not listed among the most common adverse reactions in clinical trials 1
  • The incidence appears relatively low based on available data
  • Other medications and medical conditions should be ruled out as causes
  • In children and adolescents, this side effect may be particularly distressing and affect medication adherence

The bottom line: Trazodone is a documented cause of urinary incontinence per FDA labeling 1 1, and clinicians should consider it when evaluating new-onset bedwetting in patients taking this medication.

References

Research

Trazodone dosing regimen: experience with single daily administration.

The Journal of clinical psychiatry, 1990

Research

Nocturia: a blinded, randomized, parallel placebo-controlled self-study of the effect of 5 different sedatives and analgesics.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.